Topic Editors

Division of Hematology & Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA
Department of Immunology and Microbiology, South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, Edinburg, TX, USA

Nanotechnology Therapies for Cancers

Abstract submission deadline
31 October 2026
Manuscript submission deadline
31 December 2026
Viewed by
2067

Topic Information

Dear Colleagues,

This Topic, focused on the use of nanotechnology for cancer therapies, explores the potential of nanomaterials for targeted drug delivery, enhancing efficacy and reducing side effects, with the aim of revolutionizing cancer treatment. We welcome original research articles, reviews, and perspectives on a wide range of topics related to nanotechnology-based cancer therapy, including (but not limited to) the following:

  • Current advances in nanomedicine;
  • The design, synthesis and characterization of novel nanoparticles;
  • Nanotechnology and bacterial engineering;
  • Nanotechnology and noncoding RNA;
  • Nanotechnology in drug resistance management;
  • Nanobiotics against antimicrobial resistance;
  • Multifunctional nanostructures for cancer therapy;
  • Nanotechnology in enhanced drug delivery;
  • Nanotechnology in targeted therapies;
  • Improving cancer immunotherapy through nanotechnology;
  • Improving therapeutic efficacy with nanocarriers;
  • Nanotechnology and immunoengineering;
  • Nano-immunoengineering in CAR-T cell therapy against tumor microenvironments;
  • Nanotechnology in advancements of combination cancer therapies;
  • Nanotechnology in early cancer detection and diagnosis;
  • Challenges regarding the clinical translation of nanostructures and future directions.

Dr. Deepak Parashar
Dr. Vivek K. Kashyap
Topic Editors

Keywords

  • nanotechnology
  • cancer therapy
  • targeted drug delivery systems
  • nanotechnology and immunoengineering
  • nanobiotics
  • CART therapy

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Applied Nano
applnano
- 5.9 2020 18.6 Days CHF 1000 Submit
Cancers
cancers
4.8 9.0 2009 17.5 Days CHF 2900 Submit
International Journal of Molecular Sciences
ijms
5.6 10.0 2000 17.5 Days CHF 2900 Submit
Journal of Functional Biomaterials
jfb
5.9 9.7 2010 15.1 Days CHF 2700 Submit
Nanomaterials
nanomaterials
4.8 10.3 2010 12.5 Days CHF 2400 Submit

Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.

MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:

  1. Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
  2. Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
  3. Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
  4. Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
  5. Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (2 papers)

Order results
Result details
Journals
Select all
Export citation of selected articles as:
17 pages, 3186 KB  
Article
Amine-Functionalized and Gold-Decorated Amine-Functionalized TiO2 Nanoparticles Modulate Breast Cancer Cell Viability
by Juan P. Muñoz, Kiamara Muñoz-Jaime, Diego Soto-Jiménez, Nachimuthu Venkatesh, Néstor Novoa and Krishnamoorthy Shanmugaraj
Int. J. Mol. Sci. 2026, 27(12), 5475; https://doi.org/10.3390/ijms27125475 - 17 Jun 2026
Viewed by 206
Abstract
Surface engineering is a key strategy for modulating the biological behavior of TiO2-based nanomaterials, with potential relevance for future localized or adjuvant approaches targeting residual cancer cells. This study evaluated whether amine functionalization and subsequent gold decoration modify the effects of [...] Read more.
Surface engineering is a key strategy for modulating the biological behavior of TiO2-based nanomaterials, with potential relevance for future localized or adjuvant approaches targeting residual cancer cells. This study evaluated whether amine functionalization and subsequent gold decoration modify the effects of TiO2 nanoparticles (TiO2NPs) on MCF7 and MDA-MB-231 breast cancer cells. The synthesized materials preserved the anatase TiO2 framework, while surface modification altered their physicochemical and optical properties. After 24 h of exposure, pristine TiO2NPs produced minimal changes in cell viability, whereas NH2-functionalized TiO2NPs (TiO2NPs-NH2) and gold-decorated NH2-functionalized TiO2NPs (Au@TiO2NPs-NH2) reduced viability in a concentration-dependent and cell line-dependent manner. These effects were more evident in the MTT assay than in Trypan Blue exclusion counting, suggesting changes in metabolic activity before extensive membrane integrity loss. Overall, the findings indicate that surface modification, rather than the TiO2 core alone, is a major determinant of the cellular response to these nanomaterials. These results provide an initial in vitro basis for further mechanistic studies evaluating surface-engineered TiO2NPs as candidate platforms for future adjuvant breast cancer strategies. Full article
(This article belongs to the Topic Nanotechnology Therapies for Cancers)
Show Figures

Figure 1

13 pages, 2306 KB  
Article
Development, Characterization, and Biological Evaluation of Clove Essential Oil Microemulsions
by José Nabor Haro-González, Jorge Alejandro Barbosa-Nuñez, Moisés Martínez-Velázquez and Hugo Espinosa-Andrews
Appl. Nano 2026, 7(2), 13; https://doi.org/10.3390/applnano7020013 - 31 May 2026
Viewed by 484
Abstract
Clove essential oils (CEOs) are widely studied because of their biological potential; however, their applications are limited because of their water immiscibility. Microemulsions (MEs) can protect, deliver, and enhance the biological activities of CEOs, including their antioxidant and cytotoxic activities. In this research, [...] Read more.
Clove essential oils (CEOs) are widely studied because of their biological potential; however, their applications are limited because of their water immiscibility. Microemulsions (MEs) can protect, deliver, and enhance the biological activities of CEOs, including their antioxidant and cytotoxic activities. In this research, the effects of ethanol as a cosurfactant and the polysorbate 80:cosurfactant mixture (Smix = 1:0, 9:1, 7:1, 5:1, 3:1, and 1:1) on the formation of CEO-MEs were evaluated via a pseudo-ternary phase diagram. After 35 days, all the systems produced clear, monodisperse, and thermodynamically stable MEs, characterized by average sizes below 25.6 nm and low polydispersity index values (<0.21). The Smix dose–response experiments without CEO revealed that the Smix ratios of 1:1 and 3:1 resulted in the lowest cytotoxicity to HT-29 (colorectal adenocarcinoma) cells. The antioxidant capacity of the CEO-ME was greater than that of the CEO. Finally, the CEO-MEs enhanced the in vitro cytotoxic activity of the CEO against Caco-2, HT-29, HeLa, PC-3, and A549 cancer cells. These findings provide valuable information for the development of low-energy clove essential oil MEs for potential incorporation into functional foods and pharmaceutical products. Full article
(This article belongs to the Topic Nanotechnology Therapies for Cancers)
Show Figures

Graphical abstract

Back to TopTop